Alterity Therapeutics Cash Flow Statement (2009-2025) | ATHE

Cash Flow Statement Jun2009 Dec2009 Jun2010 Dec2010 Jun2011 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2021 Dec2022 Dec2023 Dec2024 Dec2025
Operating Activities
Net Income (Quarter) -0.00B-0.00B-0.00B-0.00B
Depreciation and Depletion (Quarter) 0.00B0.00B-0.00B0.00B-0.00B165.030.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Cash from Discontinued Operations (Quarter) -0.00B-0.00B-0.00B
Gains from Investment Securities (Quarter) -0.00B0.00B
Cash from Operations (Quarter) -0.01B-0.00B-4839.60B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter) 0.00B0.00B-0.00B0.00B-0.00B165.030.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Change in Working Capital
Change in Receivables (Quarter) 0.00B-0.00B-299.00130.00-2.71B-0.00B0.00B-0.00B0.00B-0.00B-884.500.00B-0.00B-0.00B0.00B
Change in Account Payables (Quarter) -0.00B0.00B0.00B-0.00B164.74B-0.01B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B0.01B-0.00B
Change in Accured Expenses (Quarter) 0.00B0.00B0.00B-0.00B-3.54B0.00B-0.00B0.00B0.00B-824.180.00B0.00B-0.00B0.00B
Other Working Capital Changes (Quarter) 0.00B0.00B-0.00B0.00B1,474.69B-0.00B-0.00B-0.00B-0.00B0.00B143.75-0.00B-0.00B-0.00B0.00B
Investing Activities
Capital Expenditures (Quarter) -0.00B-0.00B-0.00B-0.00B
Divestments (Quarter) -0.00B
Cash from Investing Activities (Quarter) -0.00B-0.00B-0.00B-0.00B
Financing Activities
Cash from Financing Activities (Quarter) -0.00B-0.00B0.00B0.00B
Additional items
Exchange Rate Effect (Quarter) -0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B-0.00B
Change in Cash (Quarter) -0.00B-0.00B-0.01B-0.00B
Free Cash Flow (Quarter) -0.00B-4839.60B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B
Net Cash Flow (Quarter) -0.00B-4839.60B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.00B-0.01B